Magnus Pfahl

Person

Solana Beach, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted heterocycles for the treatment of diabetes and other di...
- Patent number 7,226,940
- Issue date Jun 5, 2007
- Incyte San Diego, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles for the treatment of diabetes and other diseases
- Patent number 7,196,108
- Issue date Mar 27, 2007
- Incyte San Diego Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic derivatives for the treatment of cancer and other prol...
- Patent number 7,153,875
- Issue date Dec 26, 2006
- Incyte San Diego
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic amide derivatives for the treatment of diabetes and ot...
- Patent number 7,102,000
- Issue date Sep 5, 2006
- Incyte San Diego Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimers of retinoid X receptors (RXRS) and other steroid hormo...
- Patent number 7,098,310
- Issue date Aug 29, 2006
- Ligand Pharmaceuticals
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted heterocycles for the treatment of hypercholesteremia,...
- Patent number 7,071,218
- Issue date Jul 4, 2006
- Incyte San Diego Incorporated
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimers of retinoid X receptors (RXRS) and other steroid hormo...
- Patent number 7,026,125
- Issue date Apr 11, 2006
- Ligand Pharmaceuticals
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazolidinedione derivatives for the treatment of diabetes and ot...
- Patent number 6,974,826
- Issue date Dec 13, 2005
- Incyte San Diego Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis inducing adamantyl derivatives and their usage as anti-ca...
- Patent number 6,825,226
- Issue date Nov 30, 2004
- Galderma Research & Development, S.N.C.
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thiazolidinedione derivatives for the treatment of diabetes and oth...
- Patent number 6,765,013
- Issue date Jul 20, 2004
- Incyte San Diego
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of inhibiting transcription utilizing nuclear receptors
- Patent number 6,683,047
- Issue date Jan 27, 2004
- The Burnham Institute
- Magnus Pfahl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Heterocyclic derivatives for the treatment of diabetes and other di...
- Patent number 6,515,003
- Issue date Feb 4, 2003
- Maxia Pharmaceuticals, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis inducing adamantyl derivatives and their usage as anti-ca...
- Patent number 6,462,064
- Issue date Oct 8, 2002
- Galderma Research & Development S.N.C.
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Retinoic acid receptor ε(rarε)
- Patent number 6,335,159
- Issue date Jan 1, 2002
- The Burnham Institute
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Apoptosis inducing adamantyl derivatives and their usage as anti-ca...
- Patent number 6,127,415
- Issue date Oct 3, 2000
- Galderma Research & Development, S.N.C.
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting transcription utilizing nuclear receptors
- Patent number 6,004,748
- Issue date Dec 21, 1999
- La Jolla Cancer Research Foundation
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bridged bicyclic aromatic compounds and their use in modulating gen...
- Patent number 5,837,725
- Issue date Nov 17, 1998
- SRI International
- Marcia I. Dawson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RXR homodimer formation
- Patent number 5,824,484
- Issue date Oct 20, 1998
- La Jolla Cancer Research Foundation
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RXR homodimer formation
- Patent number 5,712,093
- Issue date Jan 27, 1998
- The Burnham Institute
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of inhibiting transcription utilizing nuclear receptors
- Patent number 5,643,720
- Issue date Jul 1, 1997
- The Burnham Institute
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RXR homodimer formation
- Patent number 5,552,271
- Issue date Sep 3, 1996
- La Jolla Cancer Research Foundation
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bridged bicyclic aromatic compounds and their use in modulating gen...
- Patent number 5,466,861
- Issue date Nov 14, 1995
- SRI International
- Marcia L. Dawson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods using estrogen receptor as a constitutive transcriptional a...
- Patent number 5,183,736
- Issue date Feb 2, 1993
- La Jolla Cancer Research Foundation
- Magnus Pfahl
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Thyroid hormone receptor
- Patent number 5,144,007
- Issue date Sep 1, 1992
- La Jolla Cancer Research Foundation
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Heterocyclic amide derivatives for the treatment of diabetes and ot...
- Publication number 20060241138
- Publication date Oct 26, 2006
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted heterocycles for the treatment of hypercholesteremia,...
- Publication number 20060160796
- Publication date Jul 20, 2006
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocycles for the treatment of diabetes and other di...
- Publication number 20060004059
- Publication date Jan 5, 2006
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RXR activating molecules
- Publication number 20050209286
- Publication date Sep 22, 2005
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazolidinedione derivatives for the treatment of diabetes and ot...
- Publication number 20050070581
- Publication date Mar 31, 2005
- Incyte San Diego, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted dihydronaphthalene and isochroman compounds for the tre...
- Publication number 20050038098
- Publication date Feb 17, 2005
- Catherine Tachdjian
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzoxazole, benzothiazole, and benzimidazole derivatives for the t...
- Publication number 20050014767
- Publication date Jan 20, 2005
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-Substituted thiazolidinone and oxazolidinone derivatives for the...
- Publication number 20040097566
- Publication date May 20, 2004
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic heterocycles for the treatment of diabetes and other diseases
- Publication number 20040034004
- Publication date Feb 19, 2004
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic amide derivatives for the treatment of diabetes and ot...
- Publication number 20030216432
- Publication date Nov 20, 2003
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiazolidinedione derivatives for the treatment of diabetes and oth...
- Publication number 20030153606
- Publication date Aug 14, 2003
- Maxia Pharmaceuticals, Inc.
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted heterocycles for the treatment of hypercholesteremia,...
- Publication number 20030144329
- Publication date Jul 31, 2003
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RXR activating molecules
- Publication number 20030105333
- Publication date Jun 5, 2003
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxime derivatives for the treatment of dyslipidemia and hypercholes...
- Publication number 20030083357
- Publication date May 1, 2003
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Apoptosis inducing adamantyl derivatives and their usage as anti-ca...
- Publication number 20030073745
- Publication date Apr 17, 2003
- Magnus Pfahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocyclic derivatives for the treatment of cancer and other prol...
- Publication number 20020143182
- Publication date Oct 3, 2002
- Magnus Pfahl
- C07 - ORGANIC CHEMISTRY

Magnus Pfahl

Person

Patents Grantslast 30 patents

Substituted heterocycles for the treatment of diabetes and other di...

Bicyclic heterocycles for the treatment of diabetes and other diseases

Heterocyclic derivatives for the treatment of cancer and other prol...

Heterocyclic amide derivatives for the treatment of diabetes and ot...

Heterodimers of retinoid X receptors (RXRS) and other steroid hormo...

N-substituted heterocycles for the treatment of hypercholesteremia,...

Heterodimers of retinoid X receptors (RXRS) and other steroid hormo...

Imidazolidinedione derivatives for the treatment of diabetes and ot...

Apoptosis inducing adamantyl derivatives and their usage as anti-ca...

Thiazolidinedione derivatives for the treatment of diabetes and oth...

Method of inhibiting transcription utilizing nuclear receptors

Heterocyclic derivatives for the treatment of diabetes and other di...

Apoptosis inducing adamantyl derivatives and their usage as anti-ca...

Retinoic acid receptor &#x03B5;(rar&#x03B5;)

Apoptosis inducing adamantyl derivatives and their usage as anti-ca...

Method of inhibiting transcription utilizing nuclear receptors

Bridged bicyclic aromatic compounds and their use in modulating gen...

RXR homodimer formation

RXR homodimer formation

Method of inhibiting transcription utilizing nuclear receptors

RXR homodimer formation

Bridged bicyclic aromatic compounds and their use in modulating gen...

Methods using estrogen receptor as a constitutive transcriptional a...

Thyroid hormone receptor

Patents Applicationslast 30 patents

Heterocyclic amide derivatives for the treatment of diabetes and ot...

N-substituted heterocycles for the treatment of hypercholesteremia,...

Substituted heterocycles for the treatment of diabetes and other di...

RXR activating molecules

Imidazolidinedione derivatives for the treatment of diabetes and ot...

Substituted dihydronaphthalene and isochroman compounds for the tre...

Benzoxazole, benzothiazole, and benzimidazole derivatives for the t...

2-Substituted thiazolidinone and oxazolidinone derivatives for the...

Bicyclic heterocycles for the treatment of diabetes and other diseases

Heterocyclic amide derivatives for the treatment of diabetes and ot...

Thiazolidinedione derivatives for the treatment of diabetes and oth...

N-substituted heterocycles for the treatment of hypercholesteremia,...

RXR activating molecules

Oxime derivatives for the treatment of dyslipidemia and hypercholes...

Apoptosis inducing adamantyl derivatives and their usage as anti-ca...

Heterocyclic derivatives for the treatment of cancer and other prol...

Retinoic acid receptor ε(rarε)